TAR-DNA binding protein-43 and alterations in the hippocampus

J Neural Transm (Vienna). 2011 May;118(5):683-9. doi: 10.1007/s00702-010-0574-5. Epub 2011 Jan 6.

Abstract

Immunocytochemistry for transactive response binding protein-43 (TDP43) was assessed in the granular cell layer of the dentate gyrus in 250 cases displaying hippocampal pathology identified by haematoxylin-eosin staining. 18%, nearly one in five displayed TDP43 immunoreactive pathology in the granular cell layer of hippocampus. This percentage increased to 43% when only subjects with hippocampal pathology other than vascular in origin were included. When only subjects with severe Alzheimer's disease-related pathology were included, 42% displayed TDP43-immunoreactive pathology, increasing to 60% when concomitant Alzheimer's disease and α-synuclein pathology were present. Within this setting, TDP43-immunoreactive pathology was observed to be present in 6% of subjects with hippocampal pathology but without any cognitive impairment. Our findings justify assessment of TDP43 pathology in every case where a pathological alteration is observed in the hippocampus using a routine stain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / pathology
  • Brain Diseases / pathology*
  • Chi-Square Distribution
  • DNA-Binding Proteins / metabolism*
  • Female
  • Hippocampus / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Vascular Diseases / complications
  • Vascular Diseases / pathology
  • alpha-Synuclein / metabolism

Substances

  • DNA-Binding Proteins
  • alpha-Synuclein